P/E ratio for Cerus (CERS)
P/E ratio as of April 2024 (TTM): -5.90
According to Cerus's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.89655. At the end of 2022 the company had a P/E ratio of -14.6.
P/E ratio history for Cerus from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -14.6 | -33.54% |
| 2021 | -22.0 | 14.28% |
| 2020 | -19.2 | 136.86% |
| 2019 | -8.12 | -29.57% |
| 2018 | -11.5 | 90.91% |
| 2017 | -6.04 | -13.97% |
| 2016 | -7.02 | -35.61% |
| 2015 | -10.9 | -13.89% |
| 2014 | -12.7 | 25.56% |
| 2013 | -10.1 | -4.32% |
| 2012 | -10.5 | 31.67% |
| 2011 | -8.00 | 33.33% |
| 2010 | -6.00 | 108.04% |
| 2009 | -2.88 | 266.69% |
| 2008 | -0.7865 | -82.84% |
| 2007 | -4.58 | -87.48% |
| 2006 | -36.6 | -312.89% |
| 2005 | 17.2 | -922.26% |
| 2004 | -2.09 | 41.94% |
| 2003 | -1.47 | -75.25% |
| 2002 | -5.96 | -57.56% |
| 2001 | -14.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | 89.2 | -1,613.29% | 🇺🇸 USA |
 Utah Medical Products UTMD | 14.2 | -340.27% | 🇺🇸 USA |
 Haemonetics HAE | 35.9 | -709.09% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -0.3174 | -94.62% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.